"Northwest Medical Specialties offers comprehensive cancer treatment that includes screening and treating breast cancer, skin cancer, kidney cancer, and more. We also treat infectious diseases such as sinusitis, skin infections, and bone infections."

During the past decade, NorthWest Medical Specialties, PLLC conducted 215 clinical trials. In the 10-year time frame, 215 clinical trials started and 121 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 87 clinical trials were completed. i.e. 110.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NorthWest Medical Specialties, PLLC" #1 sponsor was "National Cancer Institute (NCI)" with 80 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "Novartis Pharmaceuticals" with 18 trials sponsored and "Hoffmann-La Roche" with 18 trials sponsored. Other sponsors include 142 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NorthWest Medical Specialties, PLLC" #1 collaborator was "National Cancer Institute (NCI)" with 78 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator and "Genentech, Inc." with 4 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "NorthWest Medical Specialties, PLLC" are "Breast Cancer" (29 trials), "Chronic Lymphocytic Leukemia" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Non-Small Cell Lung Cancer" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "NorthWest Medical Specialties, PLLC" in a lesser frequency.

Most popular intervention types in "NorthWest Medical Specialties, PLLC" are "Drug" (265 trials), "Other" (106 trials), "Biological" (86 trials), "Procedure" (43 trials) and "Radiation" (25 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (56 trials), "Quality-of-Life Assessment" (42 trials), "Paclitaxel" (37 trials), "Carboplatin" (34 trials) and "Nivolumab" (32 trials). Other intervention names were less common.

The vast majority of trials in "NorthWest Medical Specialties, PLLC" are 257 trials for "All" genders, 50 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "NorthWest Medical Specialties, PLLC". undefined are not yet recruiting, 68 are recruiting, 110 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 94 completed trials in NorthWest Medical Specialties, PLLC, 2 suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in NorthWest Medical Specialties, PLLC, 37 "Phase 1" clinical trials were conducted, 146 "Phase 2" clinical trials and 142 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".

NorthWest Medical Specialties, PLLC has several departments that took part in Clinical trials: "Northwest Medical Specialties PLLC" - 4 trials, "Hematology Oncology Northwest, P.C." - 2 trials